BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19575287)

  • 1. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
    Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
    Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Complications in Patients with Hyper IgM Syndrome.
    Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
    J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
    Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
    Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
    Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
    Front Immunol; 2018; 9():1761. PubMed ID: 30131802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
    Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
    Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
    Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
    Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
    Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
    Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
    An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
    Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
    J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
    Lanzi G; Ferrari S; Vihinen M; Caraffi S; Kutukculer N; Schiaffonati L; Plebani A; Notarangelo LD; Fra AM; Giliani S
    Blood; 2010 Dec; 116(26):5867-74. PubMed ID: 20702779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hyper IgM syndrome--an evolving story.
    Etzioni A; Ochs HD
    Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of somatic hypermutations in the IgM switch region in human B cells.
    Horiuchi K; Imai K; Mitsui-Sekinaka K; Yeh TW; Ochs HD; Durandy A; Nonoyama S
    J Allergy Clin Immunol; 2014 Aug; 134(2):411-9. PubMed ID: 24836470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.